Presented:
Mismatch Repair Deficiency Testing for Immune Checkpoint Blockade Therapy: Immunohistochemistry vs Microsatellite Instability
Presented at the 2018 Annual Meeting of the American Society of Clinical Oncology
Presented:
Identifying New Biomarkers and Targeted Molecules for Immunotherapy Using Targeted RNA Next Generation Sequencing
Presented at the 2018 Annual Meeting of the American Society of Clinical Oncology
Presented:
Efficient Large Scale Cell Classification and Analysis for MultiOmyx™ Assays: A Deep Learning Approach
Presented at the 2018 Annual Meeting of the American Association for Cancer Research
Presented:
Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification
Presented at the 2018 Annual Meeting of the American Association for Cancer Research
Presented:
Tumor-Infiltrating Myeloid Cells – Using MultiOmyx™ to Distinguish between TAMs, TANs, and MDSCs in the Pancreatic Tumor Microenvironment
Presented at the 2018 Annual Meeting of the American Association for Cancer Research
Presented:
Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification
Published in Springer Breast Cancer Research and Treatment, March 2018
Presented:
Correlation of MET gene amplification and TP53 mutation with PD-L1 expression in non-small cell lung cancer
Published in Oncotarget, February 2018
Presented:
Use of CD42b immunohistochemical stain for the detection of Histoplasma
Published in Annals of Diagnostic Pathology, February 2018
Presented:
Prostatectomy-based validation of combined urine and plasma test for predicting high grade prostate cancer
Published in The Prostate, January 2018
Presented:
Clonal Hematopoiesis in Normal Individuals Is Not Random and Likely Reflects Early MDS
Presented at the 2017 Annual Meeting of the American Society of Hematology